Skip to main content
Equibles

Creative Planning

Position in IDYA — IDEAYA Biosciences, Inc.

CIK 1540235 OVERLAND PARK, KS
Back to IDYA Full portfolio

Position in IDYA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$5,612,190
+$779,858 QoQ
Shares Held
150,582
+3.8% QoQ
Ownership
0.156%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#69
of 286 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 1% Shared 0% None 99%

Common Shares in IDYA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Creative Planning holds $457,365,908 across 219 Biotechnology names. IDYA ranks #24 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 127,672 $63,418,511
2 REGN
Regeneron Pharmaceuticals, Inc.
 36,949 $23,039,178
3 EXEL
Exelixis, Inc.
 270,292 $14,706,586
4 INCY
Incyte Corp
 110,664 $12,544,870
5 CYTK
Cytokinetics Inc
 141,939 $12,091,783
6 RVMD
Revolution Medicines, Inc.
 64,120 $12,008,393
7 ARGX
Argenx SE
 12,744 $11,823,500
8 BMRN
Biomarin Pharmaceutical Inc
 153,161 $8,763,872

All Filings in IDYA

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,612,190 150,582
2026-03-31 $4,832,332 145,028
2025-12-31 $4,703,421 136,055
2025-09-30 $3,616,208 132,900
2025-06-30 $2,557,797 121,684
2025-03-31 $999,458 61,017
2024-12-31 $472,853 18,399
2024-09-30 $274,886 8,677
2024-03-31 $308,432 7,029
2023-12-31 $205,225 5,768